Scientists in countries with the most restrictive policies on research cloning may not be able to take advantage of the international consortium based in South Korea, which was hailed this month as a means to provide stem cells to researchers living in restrictive environments. Most U.S. researchers are allowed to import the lines, but researchers in Canada and Germany cannot, and some experts are voicing concerns about how the consortium will handle ethical and commercial issues.